How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Environmental and Sustainability · Forecast 2027–2033
Ultrafiltration Tubes Market
- By Material Type: Polyethersulfone (PES), Polyvinylidene Fluoride (PVDF), Regenerated Cellulose (RC), Nylon, Polypropylene
- By Membrane Configuration: Hollow Fiber, Flat Sheet, Spiral Wound, Tubular
- By Molecular Weight Cut-Off (MWCO): 1 kDa - 10 kDa, 10 kDa - 30 kDa, 30 kDa - 100 kDa, 100 kDa - 300 kDa
- By End-User Industry: Pharmaceutical & Biotechnology, Food & Beverage, Water & Wastewater Treatment, Chemical Processing, Healthcare & Diagnostics
- By Application: Protein Concentration and Purification, Clarification and Sterilization, Desalting and Buffer Exchange, Cell Harvesting, Wastewater Treatment
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Polyethersulfone (PES) leads By Material Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 10 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 289 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.182 →
- 12 Company Profiles 10 players: SWOT & benchmarking p.190 →
Full report · locked preview
Everything inside the Ultrafiltration Tubes Market report
A complete, evidence-based study - 12 chapters and 121 sections covering market size, segmentation across 5 axes, regional analysis and 10 company profiles, forecast to 2033.
Segmentation covered
Material Type 5
Membrane Configuration 4
Molecular Weight Cut-Off (MWCO) 4
End-User Industry 5
Application 5
Companies profiled
Merck KGaA (MilliporeSigma)
GE Healthcare Life Sciences (Cytiva)
Sartorius AG
Pall Corporation (Danaher Corporation)
3M Company
Asahi Kasei Corporation
TAMI Industries
Pall Life Sciences
Eppendorf AG
Pall Corporation
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
10 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Merck KGaA (MilliporeSigma)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →GE Healthcare Life Sciences (Cytiva)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Sartorius AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Pall Corporation (Danaher Corporation)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →3M Company
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.178 →Asahi Kasei Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →TAMI Industries
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Pall Life Sciences
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Eppendorf AG
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.202 →Pall Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.209 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$6,229M by 2033 · 6.1% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Polyethersulfone (PES)47.2
- Polyvinylidene Fluoride (PVDF)7.6
- Regenerated Cellulose (RC)15.7
- Nylon10.1
- Polypropylene19.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,277M → $2,076M · 6.3%
Europe$890.0M → $1,580M · 7.4%
Asia Pacific$812.6M → $1,329M · 6.3%
Latin America$503.1M → $768.7M · 5.4%
Middle East and Africa$387.0M → $598.3M · 5.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.092026
6.092027
6.112028
6.122029
6.132030
6.152031
6.162032
6.162033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Merck KGaA (MilliporeSigma)24.1
- GE Healthcare Life Sciences (Cytiva)19.9
- Sartorius AG8.7
- Pall Corporation (Danaher Corporation)5.8
- 3M Company6.5
- Asahi Kasei Corporation7.0
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Material Type11.2%
Membrane Configuration22.3%
Molecular Weight Cut-Off (MWCO)17.9%
End-User Industry20.6%
Application28.0%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.7
- Europe24.9
- Asia Pacific20.9
- Latin America12.1
- Middle East and Africa9.4
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Merck KGaA (MilliporeSigma) | 74 | 87 | 78 | 83 | 97 | 82 | 84 |
| GE Healthcare Life Sciences (Cytiva) | 68 | 93 | 92 | 81 | 92 | 82 | 85 |
| Sartorius AG | 73 | 64 | 77 | 66 | 65 | 65 | 68 |
| Pall Corporation (Danaher Corporation) | 72 | 78 | 76 | 71 | 76 | 75 | 75 |
| 3M Company | 65 | 60 | 55 | 60 | 56 | 58 | 59 |
| Asahi Kasei Corporation | 64 | 71 | 65 | 65 | 59 | 46 | 62 |
| TAMI Industries | 56 | 51 | 48 | 50 | 48 | 43 | 49 |
| Pall Life Sciences | 60 | 49 | 36 | 50 | 58 | 45 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Merck KGaA (MilliporeSigma)
- GE Healthcare Life Sciences (Cytiva)
- Sartorius AG
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Merck KGaA (MilliporeSigma) | ◐ | ◐ | ◐ | ◐ | ✓ | ✓ |
| GE Healthcare Life Sciences (Cytiva) | ◐ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Sartorius AG | ◐ | − | ✓ | − | ✓ | ✓ |
| Pall Corporation (Danaher Corporation) | ◐ | ✓ | ◐ | ◐ | ◐ | ◐ |
| 3M Company | ◐ | ◐ | − | − | ◐ | ◐ |
| Asahi Kasei Corporation | ✓ | ◐ | − | − | ◐ | − |
| TAMI Industries | − | − | − | − | − | − |
| Pall Life Sciences | ◐ | − | − | ◐ | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1GE Healthcare Life Sciences (Cytiva)85
2Merck KGaA (MilliporeSigma)84
3Pall Corporation (Danaher Corporation)75
4Sartorius AG68
5Asahi Kasei Corporation62
63M Company59
7Pall Life Sciences50
8TAMI Industries49
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Merck KGaA (MilliporeSigma)GE Healthcare Life Sciences (Cytiva)
Challenger2
Strong scale, closing on the leaders.
Sartorius AGPall Corporation (Danaher Corporation)
Contender2
Focused players with pockets of strength.
3M CompanyAsahi Kasei Corporation
Niche2
Specialists in a single segment or region.
TAMI IndustriesPall Life Sciences
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Material Type in North America, then scale across Ultrafiltration Tubes Market — a $358M beachhead inside a $5.62B market.
Beachhead (SOM)$358Mobtainable near-term
Serviceable (SAM)$2.28Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Polyethersulfone (PES)
Best fit — highest urgency & budget in Material Type.
Economic buyer78 fit
Polyvinylidene Fluoride (PVDF)
Strong fit — clear ROI and a fast path to value.
End user66 fit
Regenerated Cellulose (RC)
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Material Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Membrane Configuration & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Molecular Weight Cut-Off (MWCO)
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel27%
Digital / self-serve21%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Material Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Ultrafiltration Tubes Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified42%
Sales qualified25%
Evaluation12%
Closed-won6%
$16.6KCAC
$95KLTV
5.7:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Ultrafiltration Tubes Market is a durable-growth opportunity — $7.22B by 2033, compounding at 7.7%.
TAM · 2025$3.98Btoday
TAM · 2033$7.22Bforecast
CAGR7.7%2027–2033
Cumulative$49.1Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$7.22BTotal addressable market
SAM$2.61BServiceable available market
SOM$436MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →7.7% CAGR
Demand compounds through 2033, outpacing GDP across Material Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Material Type moving from early to mainstream — durable secular demand.
Consolidation upside
10+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$7.22BLarge & growingTAM by 2033 at 7.7% CAGR
$2.61BServiceable nowreachable with today’s model
$436MBeachhead winobtainable near-term share
10+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.63BBear5.0% CAGR
$7.22BBase7.7% CAGR
$9.25BBull10.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Membrane Configuration optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Ultrafiltration Tubes Market — a $3.63B market by 2033. Plan: grow share from 9.4% to 16.9%.
Market size · 2033$3.63Btotal addressable
Market CAGR5.9%2027–2033
Target share16.9%from 9.4% today
Revenue ambition$613Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.4% | 16.9% | Behind |
| Revenue | $322M | $613M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 32.8% | 41.4% | On track |
| Customer retention | 84.5% | 93.8% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Material Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Membrane Configuration capability
A defensible second engine — invest in Membrane Configuration to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Material Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Membrane Configuration
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $80M capacity & capability investment
- Greenlight bolt-on M&A in Membrane Configuration
- Authorise North America expansion plan
- Fund R&D program for Material Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeAhead
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Ultrafiltration Tubes Market conversation — a $7.01B market you can size, segment and defend in minutes.
Market size · 2033$7.01Btotal opportunity
Growth4.8%CAGR to 2033
Addressable buyers1,043+accounts in scope
Typical ROI5.6×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Material Type
Goal Grow share in Material Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.6×return on cost, year one
< 3 mopayback period
$98K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
10+players profiled in this market
Coverage includes
Merck KGaA (MilliporeSigma)GE Healthcare Life Sciences (Cytiva)Sartorius AGPall Corporation (Danaher Corporation)3M CompanyAsahi Kasei CorporationTAMI IndustriesPall Life Sciences+2 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Ultrafiltration Tubes Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Ultrafiltration Tubes Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Environmental and Sustainability · scroll →Ultrafiltration Systems and Membranes Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportUltrafiltration System Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportUltrafiltration System for Water Treatment Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportUltra Filtration Modules Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportUltrafiltration Membrane Water Purifier Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportUltrafiltration Membrane Water Filter Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportUltrafiltration Membrane Unit Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportUltra Filtration Membrane Systems Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportUltrafiltration Membrane Module Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportUltra Filtration Membrane for Seawater Desalination Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportUltrafiltration Membrane Cassette Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportUltra Filtration Membrane Cartridge Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.